A new formulation of the COMIRNATY booster "12 years of age and older, Ready
to use (Original/Omicron BA.1 Cap and Package, Multi-dose vial)" was approved
on DD/MM/YY with procedure X/0000.Additional website content relevant to this
new formulation will be available on DD/MM/YY.
COMIRNATY Original/Omicron BA.1 15/15 micrograms/per dose for dispersion
for injection, for 12 years of age and older, Ready to use (Original/Omicron BA.1
Cap and Package, Multi-dose vial)
This site is intended for Healthcare Professionals in Kuwait.
EUA Fact Sheet for Vaccination Providers
EUA Fact Sheet for Recipients and Caregivers
EUA Fact Sheet Updates
Please be aware that Pfizer-BioNTech COVID-19 Vaccine is now available in 6 formulations. For additional information on differences across age groups and formulations please see Vaccine Formulations Guide on the home page of this website.
Label Update: Effective 31 AUG 2022
Pfizer-BioNTech COVID-19 Vaccine, Bivalent, which is supplied in a multiple dose vial with an orange cap and a label with an orange border, should not be used in individuals 12 years of age and older.†
Updated shelf life for 12 years of age and older Dilute Before Use, Purple Cap formulation. Please see the Shelf Life & Storage page of this website for more information.
Important Safety Information has been updated. Please see the Safety & Efficacy page of this website for details.
*Monovalent refers to any authorised or approved COVID-19 vaccine that contains or encodes the spike protein of only the Original SARS-CoV-2.
†A different presentation of Pfizer-BioNTech COVID-19 Vaccine, Bivalent supplied in a single dose and multiple dose vials with gray caps and labels with gray borders is available for use in individuals 12 years of age and older.
Click below to view:
• EUA Fact Sheet for Vaccination Providers - 12 year of age and older Dilute Before Use, Purple Cap
• EUA Fact Sheet for Vaccination Providers - 5 through 11 years of age Dilute Before Use, Orange Cap
For Healthcare Professionals in Kuwait only